You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 237 No. 11, March 14, 1977 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Collagen Disease in Children

A Review of 71 Cases

William P. Coleman III, MD; William P. Coleman, MD; Vincent J. Derbes, MD; Henry W. Jolly, Jr, MD; Lee T. Nesbitt, Jr, MD

JAMA. 1977;237(11):1095-1100.


Abstract

Seventy-one children with the diagnosis of systemic lupus erythematosus (SLE) (39 cases), dermatomyositis (25 cases), or scleroderma (7 cases) were studied retrospectively. The children with SLE were much sicker than those with the other two diseases and were found to have a poorer prognosis than adults with SLE. In general, the earlier the age of onset, the poorer the prognosis. Early gastrointestinal bleeding, abnormal renal findings, and cardiac abnormalities heralded early death from SLE. The peak incidence of SLE near the time of puberty suggests hormonal influence on this disorder in children. Survival rates and morbidity improved as the treatment improved. Corticosteroids were the main therapeutic agents. The patients with scleroderma also received varying doses of vitamin E, penicillamine, chloroquine hydrochloride, and salicylates. The antimetabolites were used to treat SLE starting in the late 1960s.

(JAMA 237:1095-1100, 1977)



Author Affiliations

From the Departments of Dermatology (Dr Coleman III), Medicine (Dr Coleman), and Allergy-Dermatology (Dr Derbes), Tulane University School of Medicine; the Department of Allergy, Ochsner Medical Institutions (Dr Coleman); and the Department of Dermatology, Louisiana State University School of Medicine (Drs Jolly and Nesbitt); New Orleans.


Footnotes

Read in part at the meeting of the American Medical Association, Section on Allergy, New York, June 25, 1973.

Reprint requests to Ochsner Medical Foundation, 1516 Jefferson Hwy, New Orleans, LA 70121 (Dr Coleman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Raynaud's Phenomenon in Children: A Retrospective Review of 123 Patients
Nigrovic et al.
Pediatrics 2003;111:715-721.
ABSTRACT | FULL TEXT  

Prognostic Significance of Raynaud's Phenomenon in Children
Jung and Dent
CLIN PEDIATR 1983;22:22-25.
ABSTRACT  

Circumscribed Scleroderma With Immunologic Evidence of Systemic Lupus Erythematosus: Report of a Case and Review of the Literature
Mitchell et al.
Arch Dermatol 1980;116:69-73.
ABSTRACT  

Clinical Syndromes of Myasthenia in Infancy and Childhood: A Review
Fenichel
Arch Neurol 1978;35:97-103.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.